| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G/A | Report | PASSAGE BIO, INC. | Aug 9, 2024 | |
| SC 13G | Report | IBIO, INC. | Apr 1, 2024 | |
| SC 13G | Report | PASSAGE BIO, INC. | Mar 29, 2024 | |
| SC 13G | Report | GH RESEARCH PLC | Feb 16, 2024 | |
| SC 13G/A | Report | BIONOMICS LIMITED | Feb 14, 2024 | |
| SC 13G/A | Report | ALPINE IMMUNE SCIENCES, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | KINNATE BIOPHARMA INC. | Feb 14, 2024 | |
| SC 13G/A | Report | PASSAGE BIO, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | C4 THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | STOKE THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | CABALETTA BIO, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | PIERIS PHARMACEUTICALS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | NEUROGENE INC. | Feb 14, 2024 | |
| SC 13G | Report | C4 THERAPEUTICS, INC. | Nov 13, 2023 | |
| SC 13G | Report | STOKE THERAPEUTICS, INC. | Nov 6, 2023 | |
| SC 13G | Report | BIONOMICS LIMITED | Oct 30, 2023 | |
| SC 13G | Report | TSCAN THERAPEUTICS, INC.. | Jun 2, 2023 | |
| SC 13G/A | Report | CABALETTA BIO, INC. | Feb 14, 2023 | |
| SC 13G/A | Report | PASSAGE BIO, INC. | Feb 14, 2023 | |
| SC 13G/A | Report | PIERIS PHARMACEUTICALS, INC. | Feb 14, 2023 | |
| SC 13G/A | Report | ALPINE IMMUNE SCIENCES, INC. | Feb 14, 2023 | |
| SC 13G | Report | KINNATE BIOPHARMA INC. | Jan 23, 2023 | |
| SC 13G | Report | PARDES BIOSCIENCES, INC. | Jan 23, 2023 | |
| SC 13G | Report | NEOLEUKIN THERAPEUTICS, INC. | Dec 30, 2022 | |
| SC 13G | Report | CABALETTA BIO, INC | Oct 31, 2022 | |
| SC 13G | Report | PIERIS PHARMACEUTICALS, INC. | Oct 24, 2022 | |
| SC 13G | Report | PASSAGE BIO, INC. | Sep 29, 2022 | |
| SC 13G | Report | ALPINE IMMUNE SCIENCES, INC. | Apr 22, 2022 |